Navigation Links
Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
Date:8/22/2011

organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath concluded a Phase III metastatic melanoma study, and the Company recently completed a multi-arm Phase II trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Hepatic CHEMOSAT delivery system in April 2011. The Company has not yet received FDA approval for commercial sale of its system in the United States. For more information, please visit the Company's website at http://www.delcath.com/.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the time required to build inventory and establish commercial operations in Europe, adoption, use and resulting sales, if any, for the Hepatic CHEMOSAT delivery system in the EEA, our ability to successfully commercialize the chemosaturation system and the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, acceptability of the Phase III clinical trial data by the FDA, our ability to address the issues raised in the Refusal to File letter received from the FDA and the timing of our re-submission of our NDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the United States, approval of the current or future chemosaturation system for other indications, actions by the FDA or othe
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
2. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
3. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
4. Delcath Systems, Inc. Announces the Sale of 5,000,000 Shares of Common Stock
5. Delcath on Preliminary List of Additions to Russell Microcap® Index
6. Delcath to Present at the JMP Securities Research Conference
7. Delcath Names Harold C. Mapes as Executive Vice President of Global Operations
8. Delcath Receives Notice of European Regulatory Approval for Hepatic CHEMOSAT™ Delivery System
9. Delcath to Update Investors on FDA Meeting
10. Delcath Expands Board of Directors With Appointment of Gabriel Leung
11. Delcath to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... for the fourth quarter of 2013 on Monday, February 3, ... release after the close of trading. (Logo: ... call to discuss the operating highlights and financial results for ...
(Date:1/14/2014)... Pa. , Jan. 14, 2014 Dynamic Healthcare Services, ... announced today that it acquired Progressive Home Medical Equipment, Inc. ... 7, 2014. The terms of the acquisition were not disclosed. ... equipment ("DME") company providing a wide range of sleep, mobility, ...
(Date:1/14/2014)... , Jan. 14, 2014   NuAire , a manufacturer of ergonomically ... with Hitachi Koki of Japan ... North America . NuAire will utilize its network of ... Canada to offer assistance in application use, ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... Jan. 27 CardioGenics Holdings Inc. (OTC Bulletin ... in-vitro diagnostics segment of the Point-Of-Care (POC) diagnostic market, announced ... cartridge for its POC diagnostic device, the QL Care Analyzer. ... self-metering cartridge. , Dr. Yahia Gawad , CEO of ...
... , ... more than 30 years of research and an extensive open-label ... U.S. launch of Livea® , a doctor-developed, non-prescription, patent-pending ... the market. , (Photo: http://www.newscom.com/cgi-bin/prnh/20100127/NY44298 ) , ...
Cached Medicine Technology:CardioGenics Announces Completion of Cartridge Design for QL Care Analyzer 2CardioGenics Announces Completion of Cartridge Design for QL Care Analyzer 3WellWorld Science(R) Announces U.S. Launch of Livea(R),a Safe and Natural Appetite Control Supplement 2WellWorld Science(R) Announces U.S. Launch of Livea(R),a Safe and Natural Appetite Control Supplement 3WellWorld Science(R) Announces U.S. Launch of Livea(R),a Safe and Natural Appetite Control Supplement 4
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/17/2014)... as 10 million older Americans suffer from depression, often ... However, new research a project that followed the ... years found that Internet use among the elderly ... 30 percent. , "That,s a very strong effect," said ... information studies and media who led the project. "And ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... Cadient Group, the,premier strategic interactive marketing agency ... been recognized as part of this,year,s Philadelphia 100(R). ... the fastest-growing, privately held companies in the Philadelphia,region., ... from 46 employees to more than,175, while revenues ...
... Health Plan announced today,that it has signed an ... to the Gateway Health Plan Medicare Assured(SM) managed ... is a Medicare,approved Special Needs Plan for Ohioans ... Under the agreement, effective October 1, 2008, Gateway ...
... Competition From Alternative Medicine and Relationships With Healthcare,Facilities ... WALTHAM, Mass., Oct. 27 Decision Resources, ... focusing on pharmaceutical and,healthcare issues, has made available ... presents the top 10 highlights of the Indian ...
... PLANO, Texas, Oct. 27 You loved your,very first ... promised and filled beautifully, but several months later you ... wrinkles creeping back in. Bear,in mind that if you ... your first, you will get your Restylane(R) beauty results ...
... Tough new steps must,be taken to prevent ... for Homecare, which today announced 13 specific recommendations,that ... to the home,medical equipment (HME) sector. The Association ... past year to adopt tougher, more effective,measures to ...
... TAMPA, Fla., Oct. 27 Relations PR & Marketing ... newest client,in the firm,s rapidly expanding roster of diverse ... forward to this partnership with Relations PR &,Marketing," said ... expertise is in line with our strategy to take ...
Cached Medicine News:Health News:Cadient Group Named to the Philadelphia 100(R) as One of the Region's Fastest-Growing Privately-Held Companies 2Health News:Gateway Health Plan(R) Signs New Agreement with Cleveland Clinic Hospitals 2Health News:Top 10 Things Pharma Should Know About India - Free Paper From Decision Resources 2Health News:Longer-Lasting Restylane(R) Beauty Results Confirmed 2Health News:Longer-Lasting Restylane(R) Beauty Results Confirmed 3Health News:American Association for Homecare Proposes Aggressive 13-Point Plan to Stop Medicare Fraud and Recoup Billions; Calls Steps Essential to Medicare's Health 2Health News:American Association for Homecare Proposes Aggressive 13-Point Plan to Stop Medicare Fraud and Recoup Billions; Calls Steps Essential to Medicare's Health 3Health News:American Association for Homecare Proposes Aggressive 13-Point Plan to Stop Medicare Fraud and Recoup Billions; Calls Steps Essential to Medicare's Health 4Health News:Relations PR & Marketing Named Agency of Record for Advanced Ultrasound Services 2
... founded in 1975, is a full-service, ... clients throughout the United States and ... focuses on cutting-edge research and development ... refinement of existing diagnostic tests to ...
... ActCel Hemostatic Gauze is a collagen-like ... It is an effective, patented, hemostatic agent ... bleeding from open wounds and in body ... thrombin or collagen and is hypoallergenic. When ...
Sharp tipped straight scissors. For cutting in the iris plane or cutting peripheral membranes. May also be useful in ROP cases....
Sharp tipped illuminated scissors with a curvature of 12 mm to follow the contour of the retina. For cutting in the plane parallel to the retina, cutting membranes adherent to the retinal surface and...
Medicine Products: